Cite
HARVARD Citation
Porksen, N. et al. (2017). Novel hepato‐preferential basal insulin peglispro (BIL) does not differentially affect insulin sensitivity compared with insulin glargine in patients with type 1 and type 2 diabetes. Diabetes, obesity & metabolism. 19 (4), pp. 482-488. [Online].